Wednesday, February 10, 2010
  • Font size
  • Bookmark
  • Save

FDA: Diabetes drug Onglyza appears safe

(Reuters) UPDATED 2009-03-30
According to the U.S. Food and Drug Administration the experimental diabetes drug Onglyza (saxagliptin) appears free from the heart-related side effects that have plagued similar treatments. However, the agency will have an expert panel weigh in on whether or not the results indicate a need for a further safety study. The new approval process for diabetes drugs came about as a result of the 2007 revelation that the blockbuster pill Avandia increased heart risks. Experts say Onglyza works to reduce blood sugar in Type 2 diabetics in a manner similar to the already-approved diabetes drug Januvia.  Read full story >
See all Diabetes News
  • Font size
  • Bookmark
  • Was this helpful? Yes
  • Save

People who read this also read...